We are facing a new threat to global health. The COVID-19 pandemic made it clear to health-care providers, public health practitioners, policy makers, and communities that pathogens do not respect ...

Afghanistan's de facto authorities have made the alarming decision to ban women from studying nursing and midwifery.1 This policy, along with the broader ban on girls completing education beyond grade ...

Estimated geographical and temporal distribution of lung-cancer incidence varied across the four main subtypes worldwide. Our ...

Several therapeutic advances have been achieved over the past two decades for inflammatory bowel disease (IBD). The expanding ...

In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

All physicians are faced with the challenge of how to help patients with no approved therapies for their diseases. What are ...

The announcement by US President Donald Trump that the USA will withdraw from WHO1 will leave both a large financial gap and ...

Artificial intelligence (AI) for mammography is an early exemplar of the integration of AI systems into clinical pathways and ...

dOxford University Clinical Research Unit, Hospital for Tropical Diseases, Centre for Tropical Medicine, Oxford University, Ho Chi Minh City, Vietnam ...

aDepartment of Environmental Medicine, University of Southern Denmark, Odense, Denmark ...

The global incidence of cancer reached 20 million in 2022 and is projected to rise to 33·1 million by 2050.1 Amid the growing ...